Hi. I’m Sean Wierda. I’m a trusted strategic advisor with a knack for high stakes collaboration and problem solving.

For the last decade, I’ve been a strategy consultant and been at the centre of over 100 major growth, innovation, and transformation projects with some of the world’s most prominent executives and respected brands.

I work with senior leaders one on one to develop strategic narratives for the toughest, most complex challenges they face. When the answer isn’t black or white and a why is needed to bring hard choices to life, I develop solutions, stories and plans that help build conviction for change.

I know just how difficult it is for large, multistakeholder teams to make progress at critical moments of collaboration. I have led tens of thousands of cumulative hours of collaboration with board of directors, c-suite executives, and project teams. In situations where clarity, speed, and alignment are make or break, my expertise is in bringing process and structure to the delivery of interventions that make a lasting impact.

In the process of building a consulting practice for myself and the boutique firm I got my start with, I have gained significant experience in navigating the ‘good, bad and ugly’ of doing business with large enterprises. I have managed well over a trillion dollars in relationships–and so while it’s something I tend to shy away from, I am a subject matter expert in enterprise business development.

I have never let my schooling interfere with my education, but if you care to know, I graduated with special distinctions from Wilfrid Laurier University in Waterloo, receiving my Honours Arts degree in Philosophy.

Though I work globally, I’m based in the heart of Toronto, Canada. When I’m not exploring possible futures, facilitating high stakes conversations, and building meaningful relationships with the CEOs I advise, you can find me shredding pentatonic scales and chasing my uncatchable Shiba Inu named Rou.

I’m currently exploring themes focused on lifelong learning, disruption of incumbents, emerging pharmaceuticals, and the future of work. You can read more about what I’m thinking about here.